166 related articles for article (PubMed ID: 35784233)
21. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
22. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
23. A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.
Zhu J; Hao J; Ma Q; Shi T; Wang S; Yan J; Chen R; Xu D; Jiang Y; Zhang J; Li J
Front Oncol; 2021; 11():661040. PubMed ID: 33937076
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
Front Oncol; 2021; 11():741309. PubMed ID: 34692522
[TBL] [Abstract][Full Text] [Related]
26. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
28. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
[TBL] [Abstract][Full Text] [Related]
29. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38453817
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
33. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
34. Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Huang G; Chen R; Lu N; Chen Q; Lv W; Li B
Onco Targets Ther; 2020; 13():5155-5164. PubMed ID: 32606736
[TBL] [Abstract][Full Text] [Related]
35. [The survival prediction model of advanced gallbladder cancer based on Bayesian network: a multi-institutional study].
Tang ZH; Geng ZM; Chen C; Si SB; Cai ZQ; Song TQ; Gong P; Jiang L; Qiu YH; He Y; Zhai WL; Li SP; Zhang YC; Yang Y
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):342-349. PubMed ID: 29779309
[No Abstract] [Full Text] [Related]
36. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Nomogram for Rectal Cancer Patients With Tumor Deposits.
Zhong X; Wang L; Shao L; Zhang X; Hong L; Chen G; Wu J
Front Oncol; 2022; 12():808557. PubMed ID: 35186745
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
Front Oncol; 2021; 11():776997. PubMed ID: 34926285
[TBL] [Abstract][Full Text] [Related]
39. A New Nomogram for Predicting the Postoperative Overall Survival in Patients with Middle-Aged and Elderly Rectal Cancer: A Single Center Retrospective Study in Chinese Population.
Zheng H; Li Z; Zheng S; Li J; Yang J; Zhao E
Int J Gen Med; 2022; 15():5197-5209. PubMed ID: 35651674
[TBL] [Abstract][Full Text] [Related]
40. Construction of a Nomogram Model for Predicting Peritoneal Dissemination in Gastric Cancer Based on Clinicopathologic Features and Preoperative Serum Tumor Markers.
Bao D; Yang Z; Chen S; Li K; Hu Y
Front Oncol; 2022; 12():844786. PubMed ID: 35719995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
